Skip to Content

HP 293 (Lithium Carbonate Extended-Release 300 mg)

Pill with imprint HP 293 is Beige, Round and has been identified as Lithium Carbonate Extended-Release 300 mg. It is supplied by Heritage Pharmaceuticals Inc..

Lithium is used in the treatment of bipolar disorder; mania; schizoaffective disorder and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for HP 293

Lithium Carbonate Extended-Release

Imprint
HP 293
Strength
300 mg
Color
Beige
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimanic agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Heritage Pharmaceuticals Inc.
National Drug Code (NDC)
23155-0293
Inactive Ingredients
calcium stearate, FD&C Blue No. 2, FD&C Yellow No. 6, hypromelloses, polydextrose, polyethylene glycol, povidone, sodium chloride, sodium lauryl sulfate, sodium starch glycolate type A potato, sorbitol, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.